Abstract: The disclosed technology teaches correctly assembling a sequence of components for interacting with a user, including providing a sequence setup GUI with components that accept inputs and have input chain dependencies and outputs. The GUI supports construction of an executable sequence by connecting at least five of the components in a directed graph and tracing multiple paths through the components in the directed graph, resulting from at least one conditional branch at a first component, as the components are connected in the directed graph. Also taught is testing whether input chain dependencies of components under evaluation are satisfied when the components are invoked following any of the multiple paths and locating at least one error in use of a second component that results from failure to satisfy the input chain dependencies of the second component and reporting the error to a user, before executing the sequence and causing the error.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their preparation.

Abstract: Described herein are methods of treating a metabolic disorder in an individual in need thereof, comprising co-administering to the individual a therapeutically effective amount of an FXR modulator, and at least one second agent that is an CCR2/CCR5 antagonist, ASK1 inhibitor, DPP-IV inhibitor, caspase protease inhibitor, SGLT2 inhibitor, acetyl-CoA carboxylase (ACC) inhibitor, diacylglycerol acyltransferase-1 inhibitor, sodium-bile acid cotransporter-inhibitor, TLR-4 antagonist, PPAR alpha/delta agonist, or GLP-1 agonist, or a combination thereof.

Abstract: The present invention relates to substituted N-heterocyclyl- and N-heteroaryltetrahydropyrimidinones of the general formula (I) or salts thereof, where the radicals in the general formula (I) correspond to the definitions given in the description, and to the use thereof as herbicides, in particular for controlling broad-leaved weeds and/or weed grasses in crops of useful plants and/or as plant growth regulators for influencing the growth of crops of useful plants.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.

Abstract: Provided herein are multi-layered protective coverings, wearable multi-layered protective devices, and methods of using the multi-layered protective coverings and wearable multi-layered protective devices.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.

Abstract: Systems and methods for generating and processing modeling workflows.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.

Abstract: Systems and methods for model evaluation. A model is evaluated by performing a decomposition process for a model output, relative to a baseline input data set.

Abstract: A system may comprise one or more processors. The one or more processors may store data, associated with a plurality of documents, as stored data and may receive documents from a plurality of client devices. The documents may include a plurality of different types of data. The one or more processors may assign the documents to one or more groups based on the plurality of different types of data and may identify a group of documents of the one or more groups. The one or more processors may compare data, within documents in the group of documents, to the stored data and may transmit, to one or more devices, a result of comparing the data to the stored data.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.

Abstract: A compound having the Formula (I), or a pharmaceutically acceptable salt or solvate thereof:

Abstract: Systems and methods for model evaluation. A protected class model that satisfies an accuracy threshold is built by using: data sets for use by a modeling system being evaluated, and protected class membership information for each data set. A target for the protected class model is a protected class membership variable indicating membership in a protected class. Each predictor of the protected class model is a predictor of an evaluated model used by the modeling system. A target of the evaluated model is different from the target of the protected class model. Each predictor is a set of one or more variables of the data sets. For each predictor of the protected class model, a protected class model impact ranking value and a modeling system impact ranking value are determined.

Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.